Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Illumina, Inc. - Common Stock (NQ: ILMN )

135.22 -4.46 (-3.19%)
Streaming Delayed Price Updated: 11:53 AM EST, Jan 10, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Illumina, Inc. - Common Stock

< Previous 1 2
...
16 17 18 19 20 21 22 23 24
...
29 30 Next >
If You Invested $1000 In Ilumina 10 Years Ago, Here's How Much You Would Have Today
Illumina (NASDAQ:ILMN) has outperformed the market over the past 10 years by 7.06% on an annualized basis producing an average annual return of 18.79%. Currently, Illumina has a market capitalization... 
Via Benzinga
55 Stocks Moving In Friday's Mid-Day Session
Gainers Swvl Holdings Corp. (NASDAQ: SWVL) surged 24.4% to $7.50. Swvl Holdings 13D Filing from investor Ahmed Sabbah showed a new 6.4% stake in the company. 
Via Benzinga
Illumina Reports 41% Dip In Q1 Profits Despite 12% Jump in Sales, Reaffirms FY22 Guidance
Via Benzinga
Illumina Crushes Earnings Forecast, Though Sales Only Meet Expectations
The next-generation DNA sequencing company expects double-digit 2022 sales growth. 
Via Investor's Business Daily
Analyst Ratings For Illumina
Illumina (NASDAQ:ILMN) has observed the following analyst ratings within the last quarter: 
Via Benzinga
Cambridge Launchpad As Illumina Targets Five Million STEM Learners
SOURCE: Illumina 
Via 3BL Media
World Must Leverage Genomics to Fight Pandemics, Illumina CEO Says
SOURCE: Illumina 
Via 3BL Media
Topics Economy
Exposures Economy
The Week Ahead In Biotech (May 1-7): Phathom FDA Decision, Pfizer, Vertex Pharma Lead Earnings News, Ophthalmology Conference Presentations, And More
Biotech stocks posted weekly declines yet again in the week ending April 29, taking cues from the weak broader market sentiment. Big pharma earnings, clinical readouts and pipeline updates moved stocks... 
Via Benzinga
Illumina Announces Long-Term Strategic Partnership with Janssen
SOURCE: Illumina 
Via 3BL Media
How Collaboration Is Driving the Next Wave of Genomics
SOURCE: Illumina 
Via 3BL Media
Exposures COVID-19
A Promising Industry 4.0 Breakthrough in the Biochip Market, Award-Winning Automated Optical Inspection System Powered by Taiwan Tech
About SparkAmplify Distribution SparkAmplify was founded in 2016. It is a SaaS company based in California and Taipei, specializing in media outreach and influencer engagement. The team consists of a... 
Via PRUnderground
Illumina Supports Leading German Hospital to Accelerate Genetic Disease Diagnosis in Critically Ill Children
SOURCE: Illumina 
Via 3BL Media
Markets Pare Early Losses As Musk-Twitter Agree On Buyout Deal
U.S. indices pared early losses and closed higher Monday. Markets were trading lower to start the session as stocks continued to fall after the Fed last week indicated it may move... 
Via Benzinga
FDA Warns Against Relying On Screening Tests For Prenatal Diagnosis
The U.S. FDA is warning that noninvasive prenatal screening (NIPS) tests may provide false results, such as stating a fetus may have a genetic abnormality when the fetus was... 
Via Benzinga
Illumina Singapore Receives Best Employer Award for Third Time
SOURCE: Illumina 
Via 3BL Media
Illumina's Chief Financial Officer, Sam Samad, Selected As a San Diego Business Journal 2022 CFO of the Year
SOURCE: Illumina 
Via 3BL Media
Lessons For Elon Musk: 5 Notorious Failed Hostile Takeovers
Let’s pause to consider earlier attempts at hostile takeovers by well-respected and well-financed entities and individuals that — to ransack some Musk-worthy clichés — took off like a rocket ship but... 
Via Talk Markets
Lessons For Elon Musk: 5 Notorious Failed Hostile Takeovers
As any student of industry knows, Elon Musk is hardly the first person to attempt a hostile takeover. 
Via Benzinga
Illumina Expands Access to Genomics in Latin America Through New State-of-the-Art Solution Center
SOURCE: Illumina 
Via 3BL Media
John Frank Joins Illumina as Chief Public Affairs Officer
SOURCE: Illumina 
Via 3BL Media
Illumina Releases Annual Corporate Social Responsibility Report
SOURCE: Illumina 
Via 3BL Media
Here's How Much You Would Have Made Owning Illumina Stock In The Last 5 Years
Illumina (NASDAQ:ILMN) has outperformed the market over the past 5 years by 1.75% on an annualized basis producing an average annual return of 15.45%. Currently, Illumina has a market capitalization of... 
Via Benzinga
DNA Data Storage Alliance Welcomes 50th Member
From DNA Data Storage Alliance
Via Business Wire
3 Top S&P 500 Stock Market Gainers Today: Medicals Lead As This Sector Reverses Hard
Medical and gold stocks led the S&P 500. Transport stocks were big losers. 
Via Investor's Business Daily
April Fool
Today China pushed its iron ore price to an 8 month high to help pay for pricey oil and gas. 
Via Talk Markets
Benzinga's Top Ratings Upgrades, Downgrades For March 29, 2022
Upgrades 
Via Benzinga
Join Illumina on World Tuberculosis Day to Raise Awareness and Keep the Fight Up to Eradicate TB
SOURCE: Illumina 
Via 3BL Media
Illumina Celebrates Shannon Whitmore: A Real Time Revolutionary and Scientific Computing Innovator
SOURCE: Illumina 
Via 3BL Media
Illumina Accelerator Invests in Seven Omics Startups Advancing Breakthrough Therapeutics, Diagnostics, DNA Storage, Mental Wellness, and Sustainable Foods Applications
SOURCE: Illumina 
Via 3BL Media
Illumina Unveils Groundbreaking Comprehensive Genomic Profiling Test for Cancer in Europe
SOURCE: Illumina 
Via 3BL Media
< Previous 1 2
...
16 17 18 19 20 21 22 23 24
...
29 30 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.